The Millionaires Club A forum where gentlepersons may discuss finance and related matters
wit is appreciated - vulgarity is not

Introduction

View Introduction

Archives

View Archives

Search Archives

Info

Adding Images

Adding Links

Links

 aaa Brown attacked by M|EP

 aaa The Great GW Circus

 ADVFN

 AIM

 Barclays Stockbrokers

 BBC

 Bloomberg

 Bullion Desk

 CMC

 CNN

 Companies House

 CSY Computer Systems

 Daily Bayonet

 Dailyfx

 Digital Look

 Fark

 French Property

 FT.com

 Google

 Growthcompany Info

 IG Index

 Interactive Investor

 Live Oil Price

 London Stock Exchange

 Money AM

 Motley Fool

 MSN Money

 Nasdaq

 New York Stock Exchange

 News of the World

 Shares mag

 Sky News

 Stockchallenge

 The Daily Mail

 The Daily Telegraph

 The Dailymash

 The Financial Times

 The Guardian

 The Indepenent

 The New York Times

 The Sun

 The Times Online

 The Wall Street Journal

 Wikipedia

 Yahoo

 You tube


Current Message Return to posts
From: Denc 🗡
Jabfrit News….


Skin cancer vaccine stops relapse in trial breakthrough
Personalised mRNA jab tells immune system to hunt down melanoma tumours

Telegraph Reporters
Published 19 August 2026 8:26pm BST
A personalised vaccine for skin cancer can help stop the spread of the disease, according to a leading drug manufacturer.

Moderna, the US pharmaceutical company, announced positive results for the world’s first personalised mRNA cancer jab for melanoma in an investor update on Wednesday.

It said interim results for the vaccine, called Intismeran, showed reduced recurrence of the cancer and also stopped the disease from spreading to other parts of the body.

The drug was given to people with high-risk melanoma after they had surgery and the results have been hailed as a “landmark moment” in personalised cancer treatment.

The vaccine is custom-built for each patient in a few weeks and works by telling the body’s immune system to hunt down cancer cells and prevent the disease from coming back.

Prof Georgina Long, medical director of Melanoma Institute Australia and the study’s principal investigator, said: “Today’s results represent a landmark moment for adjuvant melanoma treatment.”

Results from the phase-three trial of more than 1,000 patients show the vaccine, in combination with MSD’s immunotherapy Keytruda medicine, almost halved the risk of recurrence in patients.



 Current Thread  Author  Time 
Jabfrit News…....[more]
 Denc 🗡  00:16:03 
>> Several experts here have suggested that their dicks will fall off by Xmas.
 Denc 🗡  00:17:02 

You must log in or register before you can post messages (you'll be returned to this page once logged in).



© 2000 sell on the internet (soti) ltd | feedback
www.the-millionaires-club.co.uk ... FTIR Investments of Geneva Place, Road Town, British Virgin Islands